Skip to main content

Drug Relief

By Jessica Hagen | 01:54 pm | September 27, 2022
  The company’s device, Primary Relief, is the latest of DyAnsys’ long list of devices to receive FDA clearance.  
By Dave Muoio | 03:29 pm | June 14, 2018
DyAnsys, a medical device company specializing in the autonomic nervous system, announced this week that it has received FDA approval for a wearable auricular neurostimulation device designed to treat symptoms of opioid withdrawal.